The root cause of preeclampsia in the human lies in the placenta, where a subpopulation of cytotrophoblast cells called extravillous trophoblasts (EVT), known to be involved in the invasion of the uterine endometrium and utero-placental arteries, become less invasive, resulting in poor perfusion of maternal blood into placenta.
Design: mRNA expression of different PGE 2 receptors (EPs) in HTR-8/Svneo cells was studied using RT-PCR. To characterize the functional significance of EP receptors in EVT, different EP receptor agonists and antagonists were used in our migration assay systems and in the measurements of intracellular concentration of Ca 2ϩ ([Ca 2ϩ ] i ) and calpain activity.
Results: Exogenous PGE 2 stimulated EVT migration both in vitro and in the villus explant cultures. Although EVT expressed mRNA for all EP receptors (EP 1-4), a functional predominance of EP1 and EP4 was demonstrated in migration assays using specific EP agonists and antagonists. EP1-receptor-mediated signaling events such as activation of phospholipase C and elevation of cytosolic free [Ca 2ϩ ] i were confirmed by the following findings: 1) exogenous PGE 2 or an EP1 agonist, but not an EP4 agonist, increased [Ca 2ϩ ] i , which could be blocked with an EP1 antagonist as well as BAPTA and thapsigargin; 2) phospholipase C inhibitor U73122, BAPTA, and thapsigargin inhibited PGE 2 -mediated migratory response of EVT; and 3) PGE 2 -mediated EVT migration was shown to be dependent on a class of Ca 2ϩ -dependent proteases called calpains, known to be involved in cell detachment from substratum during migratory responses. The presence of PGE 2 stimulated calpain activity, whereas two calpain inhibitors, calpastatin and N-Ac-Leu-Leu-methioninal (ALLM), blocked EVT migration. A HIGHLY MIGRATORY and invasive subpopulation of cytotrophoblast cells, called extravillous trophoblast (EVT), breaks out of the chorionic villi and invades the uterine decidua and its vasculature, leading to a remodeling of the utero-placental arteries. This remodeling involves disintegration of the tunica media and a replacement of the endothelium by the trophoblast, transforming the arteries into flaccid tubes to ensure a steady flow of the maternal blood into the placental sinusoids to sustain fetal growth. Although mechanisms of EVT cell invasiveness are similar to those of tumor cells (1) , in contrast to tumor cell invasion, EVT cell invasion of the uterus is stringently controlled in situ to maintain a healthy utero-placental homeostasis (2) . A breakdown in this homeostasis can manifest as trophoblast hypoinvasiveness underlying preeclampsia and certain types of intrauterine growth retardation (3) or trophoblast hyperinvasiveness, a characteristic of gestational trophoblastic neoplasias including choriocarcinomas (4) .
A large number of studies have investigated the cellular and molecular mechanisms regulating the proliferative, migratory, and invasive functions of EVT cells in situ. These studies revealed that a variety of molecules including growth factors, growth factor-binding proteins, and proteoglycans produced at the feto-maternal interface can positively or negatively regulate these functions in an orchestrated manner (reviewed in Refs. 3 and 5) . There is now a strong body of evidence to indicate that a functional deregulation of some of these molecules may contribute to the etiology of preeclampsia, a multifactorial disease (3) .
Prostanoids are small lipid molecules synthesized from arachidonic acid (AA), liberated from membrane-bound phospholipids by the action of phospholipases A2 in response to various physiological and pathological stimuli. AA is subsequently converted by cyclooxygenases (COXs) and then various isomerases and reductases to different shortlived molecules collectively named prostanoids, including prostaglandins (PGs) and thromboxanes. Of these, the most well-studied is PGE 2 , which was shown to play a major role in the events leading to the success of pregnancy and child birth, e.g. decidual response and implantation (6, 7) , immu-noprotection of the semiallogenic conceptus (8) , and parturition (9) . Derangements of some of these prostanoids have been reported both in the peripheral vasculature and in the placenta during the development of preeclampsia (10 -12) . Of these, a decline in the level of PGE 2 is believed to contribute to the increased peripheral vascular resistance in response to angiotensin II in pregnant women who are susceptible to developing preeclampsia (13) . However, the possible functional relationship of low PGE 2 level in situ to trophoblast hypoinvasiveness remains unknown. PGE 2 production in the pregnant human uterus results from a number of sources, notably the fetal membranes (14) and the decidua (8) . Although the role of decidua-derived PGE 2 in averting the alloreactivity of maternally derived lymphocytes against the conceptus has been well recognized (8, 15) , its possible functional role in regulating EVT cell migration/invasiveness remains to be examined. This role is suggested by certain striking similarities between the EVT cells and tumor cells in the molecular mechanisms responsible for invasive and migratory functions of both cell types (1) , and the findings that PGE 2 promotes tumor progression by stimulating tumor cell migration, invasiveness, and angiogenesis (16, 17) . PGE 2 exerts its biological functions on cells through four membrane-bound G protein-coupled receptors (EP1-4). EP1 receptors are coupled with G q proteins, activating phospholipase C (PLC) and elevating the intracellular concentration of Ca 2ϩ ([Ca 2ϩ ] i ); EP2 and EP4 are G s -coupled receptors, signaling by increasing the intracellular cAMP level; EP3 consists of multiple isoforms and, in general, inhibits the activity of adenylate cyclase via G i protein, decreasing the intracellular concentration of cAMP (18 -20) . Although PGE 2 stimulation of migration of breast cancer cells was shown to be mediated predominantly by EP4 receptors (17) , the functional role of individual EP receptors in EVT cell migration has never been examined. Cellular migration involves multiple processes, including adhesion, forward projection of lamellipods and filopods, cytoskeletal reorganization, cytoskeletal contraction, and detachment at the rear end (21) . The calcium-dependent cysteine protease calpain, which localizes to focal adhesions, was shown to play a major role in cell locomotion by helping detachment of the rear end of the cell (22, 23) . Because of its calcium-dependence, it is logical to suggest that calpain may play an intermediary role in EP1-mediated migration stimulation of cells by PGE 2 .
In view of high levels of PGE 2 produced by the maternal decidua during the first trimester of pregnancy (8) and a possible functional relationship between the low PGE 2 level at the fetomaternal interface and trophoblast hypomigratory phenotype in preeclampsia, in the present study we used a well-characterized first trimester human EVT cell line as well as EVT cell sprouts in first trimester chorionic villus explants in culture to explore the role of PGE 2 and various EP receptors in EVT cell migration. Because we observed the functional predominance of EP1 and EP4, we further examined certain EP1-mediated signaling events, e.g. activation of PLC, increase in cytosolic Ca 2ϩ , and activation of calpain in the stimulation of EVT cell migration by PGE 2 .
Materials and Methods

Reagents and materials
RPMI 1640 and fetal bovine serum (FBS) were purchased from GIBCO (Burlington, Ontario, Canada 
Immunofluorescence staining
Cells were allowed to grow in complete media on 12-mm glass coverslips and then were washed with ice-cold PBS. The cells were fixed with 100% methanol and then washed again with PBS. Nonspecific binding sites were blocked using normal goat serum. Primary mouse antihuman antibodies were added (1/100 dilution, 4 h at 4 C) and then secondary fluorescein isothiocyanate-labeled goat antimouse (1/100 dilution, 1 h in the dark, at room temperature). The coverslips were mounted using fluorescent mounting medium (DakoCytomation).
EVT cell line and culture
We used an EVT cell line HTR-8/Svneo (25) , produced in our laboratory by SV40 Tag immortalization of a short-lived first trimester EVT cell line called HTR8. HTR-8/Svneo cells have retained all the phenotypic and functional characteristics of the parental cells HTR8, expressing all the markers of EVT in situ: cytokeratin 7, 8, and 18, placental type alkaline phosphatase, high affinity urokinase-type plasminogen activator receptor, IGF-II mRNA and protein, HLA framework antigen w6/32, and integrins ␣1, ␣3, ␣5, ␤1, and ␣v␤3/␤5 (26). They express HLA-G when grown on laminin or Matrigel (27) and mimic the phenotypic behavior of freshly isolated cytotrophoblast cells during Matrigel invasion (28) . Their responses to the migration-stimulating ligands such as IGF-II (29), IGF binding protein 1 (IGFBP-1) (30), and urokinase-type plasminogen activator (uPA) (31) and migration-inhibitory ligands TGF-␤ (32) and decorin (33) are identical to those of the primary EVT cell line HTR-8. They were used at 88 -106 passages during the present study and cultured in RPMI 1640 supplemented with 10% FBS, 50 U/ml penicillin, and 50 g/ml streptomycin, unless specified otherwise.
Chorionic villus explant culture to examine EVT cell outgrowth
The outgrowth of EVT cells in situ was measured using a modification of earlier-reported protocols (34 -36) . Small fragments of villus tips (10 -15 mg wet weight) from placentae (n ϭ 9) at 7-to 9-wk elective pregnancy terminations (collected in accordance with the local ethics review and approval guidelines set by the Department of Obstetrics and Gynecology, University of Western Ontario) were dissected to remove fetal membranes and endometrial tissue and then placed on Millicell-CM culture dish inserts (Millipore Corp., Bedford, MA). The inserts were precoated with 200 l of 1:6 dilution of Growth Factor Reduced Matrigel (Collaborative Biomedical Products, Bedford, MA) in serumfree DMEM/F12 medium (Life Technologies, Inc., Grand Island, NY) supplemented with 50 U/ml penicillin, 50 g/ml streptomycin, and 0.25 mg/ml ascorbic acid (Sigma) at pH 7.4. Before addition of the chorionic villi, the inserts were placed at 37 C for a half hour to allow the Matrigel to polymerize, and then were placed in 24-well plates (Becton Dickinson, Franklin Lakes, NJ) containing 800 l of the same serum-free DMEM/ F12 medium with or without different treatments. Culture media was changed every 48 h and human chorionic gonadotropin (hCG) and progesterone concentrations were measured using RIA (Coat-A-Count, DPC, Los Angeles, CA) to assess the viability of the chorionic villi. At least three placentae were used for each experiment, and triplicate explants were set up for each treatment under control and experimental conditions. Identity of EVT cells in the outgrowths was confirmed with immunostaining for cytokeratin-7. Pictures of the villus explants were taken every 24 h, up to 120 h using an inverted light microscope (ϫ40 objective). The area of EVT cell outgrowth in live cultures was measured using Scion Image for Windows software (version ␤ 4.0.2; Scion Corp., Frederick, MD).
Measurement of PGE 2 production
The level of PGE 2 accumulating in 24-h serum-free culture supernatants of HTR-8/Svneo cells plated at a concentration of 1.5 ϫ 10 5 cells/ml was measured using Prostaglandin E 2 EIA Kit-Monoclonal from Cayman Chemicals, as reported earlier (17) .
RNA isolation and RT-PCR analysis of EP receptors
RT-PCR and oligoprimers for PCR analysis of EP receptors were as reported earlier (17) . Each PCR consisted of initial denaturation at 94 C for 2 min and then 40 cycles (34 cycles for EP1 only) at 94 C for 30 sec, 58 C (51 C for EP1 only) for 30 sec, 72 C for 45 sec, and an additional 5-min extension at 72 C after the last cycle, and was conducted using an Eppendorf Mastercycler Gradient (Eppendorf Scientific, Westbury, NY). GAPDH expression was used as an internal positive control for cDNAs and the sizes of the PCR products were estimated using GeneRuler (MBI Fermentas, Burlington, Ontario, Canada).
Migration assay
Migration of HTR-8/Svneo cells (chemokinesis) was measured using modification of a protocol as reported earlier (29, 30) , using 24-well Falcon notched plates and Falcon cell culture inserts with microporous polycarbonate membranes having 8.0 m pore size (Becton Dickinson). In brief, aliquots of 1 ϫ 10 5 cells suspended in 200 l serum-free RPMI 1640 medium supplemented with 0.1% BSA were added in the upper chamber, while the lower chamber was filled with 800 l serum-free medium with or without additional treatment. After incubation for 48 h at 37 C, 5% CO 2 , the upper surface of the insert membranes was wiped with cotton swabs to remove nonmigratory cells, and then the membranes were stained using Harleco Hematocolor staining kit (EM Science, Gibbstown, NJ). The absolute number of migratory cells on each membrane was scored visually using light microscope (400 ϫ magnification). Each treatment was performed in triplicates and repeated three times. For data presentation, migration indices under experimental conditions were plotted as a percentage of the controls.
Cell proliferation/survival assay
The effect of various treatments on the proliferation/survival of HTR-8/SVneo cells was assessed as reported elsewhere (33) , respectively, and ␤ was the ratio of the fluorescence at 485 nm measured at low and saturating concentrations of Ca 2ϩ (38) .
Calpain activity assay
Calpain activity was measured using a Calpain activity assay kit (catalog no. QIA120 from Calbiochem) as described elsewhere (39) . In brief, the ability of calpain to digest the synthetic substrate Suc-LLVY AMC was measured fluorometrically at excitation 380 nm and emission 460 nm in the presence of saturating or nonsaturating levels of Ca 2ϩ . The calpain activity was displayed in relative fluorescence units per milligram of protein per minute.
Statistical analysis
Migration scores were analyzed using one-way ANOVA, and then the values were normalized as a percent of the control (migration indices). Differences among treatment means were assessed by student t test. Differences of P Ͻ 0.05 were considered significant.
Results
HTR-8/Svneo cells have maintained EVT cell phenotype, produce very small amount of PGE 2 , and express all EP receptors As part of our routine phenotyping of HTR-8/Svneo cells at frequent intervals for a variety of EVT cell markers, we demonstrate here that they express cytokeratin-7 and ␣5␤1 integrin (Fig. 1A) .
The level of PGE 2 produced by these cells as measured in 24 h serum-free cell culture media was very small (ϳ0.25 pg/g cell-associated protein), roughly 1000 times less compared with first trimester human decidual cells (8) . This production was completely inhibited by indomethacin (10 mol/liter), a nonselective COX-1/COX-2 inhibitor (data not shown). An examination of mRNA expression of EP as detectable by RT-PCR revealed that HTR-8/Svneo cells express all EP receptors (EP1-EP4), as demonstrated by bands of the expected sizes of 324, 655, 398, and 366 bp, respectively (Fig. 1B) .
PGE 2 stimulates EVT migration by using multiple EP receptors
We tested the effect of exogenous PGE 2 at concentrations of PGE 2 ranging from 10 nmol/liter to 1 mol/liter on HTR-8/Svneo cell migration. In our chemokinesis assay conducted in serum-free media, after 48 h, PGE 2 induced a concentration (up to 1 mol/liter)-dependent increase of migration of these cells ( Fig. 2A) . At each concentration level, the values were significantly higher (P Ͻ 0.05) than that of the preceding concentration. Similar stimulatory effects of exogenous PGE 2 on EVT cell outgrowth were also noted in first-trimester human chorionic villus explant cultures on growth factor-reduced Matrigel under serum-free conditions. Although control explants showed no EVT cell outgrowth (data not shown), outgrowth of EVT cells was noticed at 48 h (Fig. 2B ) in the presence of 1 mol/liter PGE 2 , and the area covered by the migrant EVT cells increased further at 72 (data not shown) and 96 h (Fig. 2 , B and C).
As mentioned above, HTR-8/Svneo cells express the mRNA for all EP receptors. To elucidate which one of these receptors is involved in the stimulation of migration, we tested the effects of different receptor antagonists, SC-19220, AH-6809, and AH-23848B with highest affinities for EP1 (K i ϭ 4.5 mol/liter), EP1/EP2/DP (K i varying from 1.15-1.6 mol/liter) and EP4 (K i ϭ 13.7 mol/liter), respectively. All these compounds, in the presence of 100 nmol/liter PGE 2 , variably inhibited the migration of HTR-8/Svneo cells in a concentration-dependent manner (Fig. 3A) . The migration index declined significantly below unity at higher concentrations (1-10 mol/liter) of EP4 and EP1/EP2/DP antagonists, suggesting that they might be blocking the migrationpromoting effects of the endogenous PGE 2 . This suggestion was reinforced in a separate experiment (Fig. 3B) showing that these antagonists at the above concentrations significantly reduced the basal migration in the absence of exogenous PGE 2 .
We further investigated the effect of two EP agonists, 17-phenyl trinor PGE 2 and PGE 1 alcohol, with highest affinities for EP1 (K i ϭ 7.3 nmol/liter) and EP4 (K i ϭ 190 nmol/ liter), respectively. Both of them stimulated migration of HTR-8/Svneo cells in a dose-dependent manner, up to 1 mol/liter. However, as expected, the extent of stimulation by these agonists was lesser than that by PGE 2 at similar concentrations (Fig. 3C) . Taken together, these results suggested that both EP1 and EP4 contribute to the PGE 2 -mediated stimulation of migration of HTR-8/Svneo cells.
Using MTT assay we investigated the effect of PGE 2 (1 nmol/liter to 1 mol/liter) on the cellularity of HTR-8/ Svneo cells, because PGE 2 had been shown to have promoting effects on proliferation/survival of certain cell types (40, 41) . We found that under serum-free conditions as used for migration assays, PGE 2 at these concentrations, had no effect on proliferation/survival of HTR-8/Svneo cells (data not shown). Furthermore, neither any of the EP antagonists, SC-19220, SC-51322, AH-6809, or AH-23848B, nor the agonists 17-phenyl trinor PGE 2 or PGE 1 alcohol at the concentrations used in the migration assays affected cellularity of these cells in MTT assays. In contrast, inclusion of FBS (5 and 10%) in the media significantly increased the proliferation of EVT cells (data not shown). These data, taken together, revealed that the migration-modulating effects of these agents on EVT cells were not a consequence of effects on cell proliferation/ survival. (Fig. 5B) , demonstrat- ing the availability of Ca 2ϩ from intracellular stores. On the other hand, pretreatment of HTR-8/Svneo cells with Tg (1 mol/liter) for 30 min blocked the effect of PGE 2 (Fig. 5B) , suggesting that the transient rise of [Ca 2ϩ ] i mediated by PGE 2 is due to the release from ER. We also tested the effect of U-73122 (PLC inhibitor) on the Ca 2ϩ release. PLC has been shown in other cell types to be activated upon EP1 stimulation by PGE 2 , leading to phosphatidylinositol 4,5-bisphosphate hydrolysis, resulting in accumulation of inositol trisphosphate and diacylglycerol to elicit intracellular Ca 2ϩ mobilization (18) . U-73122, but not its inactive analog U-73343 (44), inhibited the PGE 2 -mediated Ca 2ϩ release in HTR-8/Svneo cells (Fig. 5C ).
PGE
PLC inhibitor decreases the HTR-8/Svneo cell migration
We showed that both PGE 2 and EP1 agonist 17-phenyl trinor PGE 2 increases [Ca 2ϩ ] i in HTR-8/Svneo cells presumably upon activation of EP1 receptors, through a mechanism depending on PLC activation. Therefore, we tested the effect of PLC inhibitor on HTR-8/Svneo cell migration. U73122 (1 mol/liter), and not its inactive analog U73343, inhibited migration of EVT cells (Fig. 6A) in the presence or absence of EP1 agonist 17-phenyl trinor PGE 2 , supporting the hypothesis that PGE 2 , acting through EP1 receptors, may activate PLC that plays an important role in the migration of HTR-8/Svneo cells. Interestingly, PGE 2 treatment partially rescued U73122 inhibition, suggesting a possible involvement of other EP receptors in EVT migration (Fig. 6A) . Inhibition of basal cellular migration by PLC inhibitor (Fig. 6A) indicates that PLC is required for basal migration of HTR-8/Svneo cells.
BAPTA and Tg inhibit migration of HTR-8/Svneo cells
To determine whether the rise of [Ca 2ϩ ] i by PGE 2 actively contributes to the migration stimulation, we also tested the effect of BAPTA (100 nmol/liter) and Tg (100 nmol/liter) on the migration of HTR-8/Svneo cells. Migration was measured in EVT cells preincubated for 45 min with BAPTA (100 nmol/liter) or with Tg (100 nmol/liter), followed by addition of PGE 2 or 17-phenyl trinor PGE 2 . Both compounds inhibited cellular migration at 48 h in the presence or absence of exogenous PGE 2 or 17-phenyl trinor PGE 2 (Fig. 6B) , suggesting that the intracellular Ca 2ϩ stored in the ER is required for EP1-mediated stimulation of migration. Migration-inhibitory effects of both compounds in the absence of any receptor ligand can be explained by the requirements of [Ca 2ϩ ] i for migration in response to endogenous PGE 2 as well as other mediators. A strong inhibition by Tg alone, along with the observation that PGE 2 did not significantly rescue BAPTA or Tg effects (Fig. 6B) , attest to the essential role of [Ca 2ϩ ] i requirement for migratory responses resulting from most or all endogenous mediators. In parallel experiments, these concentrations of BAPTA and Tg tested for effects on cell proliferation/survival were found to have no effects.
PGE 2 stimulates activation of calpain in HTR-8/Svneo cells as a migration-stimulatory event
A calcium-dependent neutral protease, calpain has recently been implicated in cell migration through its requirement for both detachment of cells at their trailing edge and cell spreading (22, 23) . Also, this enzyme has been found to have an important role in epidermal growth factor (EGF)-receptor-mediated cell deadhesion and motility (45) . Therefore, we first determined whether inhibition of calpain would reduce basal and also EP1-mediated EVT cell migration. We tested the effect of calpain inhibitors ALLM (10 mol/liter) and calpastatin (1 mol/liter) on HTR-8/Svneo cell migration. Both inhibitors, in the presence of 17-phenyl trinor PGE 2 (1 mol/liter), decreased migration of EVT cells at 48 h to the levels of controls (Fig. 7A) , suggesting that activation of calpain plays an important role in EP1-mediated migration of HTR-8/Svneo cells. Significant migration inhibition with these calpain inhibitors in the absence of exogenous ligand can be explained by the requirements of calpain activity for migration in response to endogenous mediators, including PGE 2 . Minor differences in migration indexes be- To further elucidate whether calpain was simply a permissive factor for EP1-mediated EVT cell migration or these cells require activation of calpain through EP1, we used a quantitative assay which measures the ability of calpain to cleave the synthetic substrate Suc-LLVY AMC and liberate AMC which is measured fluorometrically. We measured calcium-activated calpain activity in two sets: in the absence of exogenous calcium and in the presence of enzyme-saturating amounts of calcium in the assay mixture. Intracellular calcium would serve as a source of calcium cofactor for the enzyme in the assay tubes where no additional calcium had been added, even though calcium could be limiting to the enzyme. Any rise of enzyme activity in this set of assay tubes would indicate increased activity due to rise of intracellular calcium. However, in the other set of assay tubes where the enzyme had been saturated with exogenous calcium, any rise of enzyme activity would indicate an additional mechanism of activation of calpain. Treatment of HTR-8/Svneo cells with 1 mol/liter PGE 2 and EP1 agonist elicited a significant increase in calpain activity at 10 min in both sets (Fig. 7B) . Even at saturating concentrations of exogenous Ca 2ϩ in the assay mixture, calpain activity in HTR-8/Svneo cells pretreated with PGE 2 or EP1 agonist was significantly higher than controls (Fig. 7B) . This suggests that besides the rise of intracellular Ca 2ϩ , other mechanism(s) is (are) involved in EP1-receptor-mediated calpain activation.
Discussion
Migratory and invasive functions of the human EVT are tightly regulated by a variety of locally derived molecules (3, 5) . In the present paper, using a well-characterized first trimester human EVT cell line as well as first trimester chorionic villus explant cultures, it is shown for the first time that PGE 2 , a small molecule produced at the fetal-maternal interface, promotes EVT cell migration in a predominantly paracrine and, to a minor extent, autocrine manner. We have further shown that EVT cells express all the EP (EP1-4) receptors, and multiple EP receptors, in particular EP1 and EP4, mediate the migration stimulatory function of PGE 2 . We also have characterized some of the signals downstream of EP1 to show that activation of PLC, increase in [Ca 2ϩ ] i , and activation of calpain are key events in the signaling pathway responsible for migration stimulation. Signaling events resulting from activation of other EP receptors on EVT cells remain to be investigated. Results of the present study might well explain the findings of a randomized control study where daily administration of low doses of linoleic acid (which metabolizes to PG precursor AA) with calcium during pregnancy corrected the levels of PGE 2 and reduced the incidence of preeclampsia (12) . PGE 2 is a key migration-promoting molecule for a variety of cell types, including endothelial cells participating in angiogenesis (46) as well as cancer cells (17, 47) . In the latter case, it is an autocrine stimulus resulting from high levels of COX-2 expression by cancer cells, which is positively correlated with tumor progression and metastasis (17) . Although EVT cells in the first trimester human placentae show microsomal PGE synthase and COX-2 immunostaining (48) and HTR-8/SVneo cells express detectable COX-2 mRNA, as shown by RT-PCR (data not shown), they produce roughly 1000 times less PGE 2 than first trimester decidual cells (8) . These data, in combination with present functional data showing strong stimulatory effects of exogenous PGE 2 on migration of HTR-8/SVneo cells as well as outgrowth of EVT cells in villus explant cultures suggest that PGE 2 is predominantly a paracrine stimulus evidently provided by the decidua. It may represent one of the molecules in decidual extracts which has been shown to promote EVT cell outgrowth and matrix invasion in chorionic villus explant cultures (49) .
EVT cell sprouting in villus explant cultures is a combined outcome of cytotrophoblast proliferation and differentiation of cells along the extravillous pathway with the acquisition of a migratory and invasive phenotype. Although we have not attempted to dissect the relative contribution of proliferation vs. migration in the PGE 2 stimulation of EVT cell outgrowth in our explant culture system, several observations are highly pertinent: 1) under the serum-free conditions of our explant cultures on growth factor-reduced Matrigel, no outgrowth was detected in the absence of PGE 2 , although outgrowths are detectable on traditional Matrigel; 2) cells spread out like a carpet from preexisting mini-sprouts in a villus fragment (as seen at 0 h in Fig. 2B); and 3 ) the explant size appeared to shrink with time, indicative of cells migrating out of the preexisting sprouts rather than significant proliferation in these sprouts. Although these observations combined with the absence of PGE 2 effect on proliferation of HTR-8/SVneo cells would suggest that the increase in outgrowth size in explants with time (as shown in Fig. 2C ) is primarily a result of increased migration, further studies are needed with explant cultures to identify the relative contribution of cell proliferation, if any, under the influence of PGE 2 .
Using EP receptor antagonists and agonists we have established that multiple EP receptors participate in PGE 2 -mediated migratory response of EVT cells. Although we have firmly established the roles of EP1 and EP4, the roles of EP2 and EP3 were not excluded. The role of EP receptor class participating in migratory responses in other cells depends on the cell type. For example, PGE 2 stimulation of migration of highly metastatic breast cancer cell lines was shown to be mediated predominantly by EP4 and, to some small extent, by EP2 (17) . In the case of Langerhans cells, it was shown to be EP4 (50) , whereas a role of EP3 was demonstrated in human arterial smooth muscle cells both by the use of EP3 agonist as well as by EP3 overexpression in these cells (51) .
EP1 receptor is a G q -coupled receptor and was shown in many cells to activate PLC, leading to an increase in the The present study is the first to report PGE 2 -mediated cellular calpain activation. The calpain family of cysteine proteases comprises of 13 members of which m-and -calpain are ubiquitously expressed and are the most well-studied calpains (52) . Both calpains have been implicated in cellular adhesion and migration. Integrin-mediated cellular migration was shown to require -calpain because of its involvement in cellular attachment as well as detachment from the substratum; a calpain-mediated proteolytic breakdown of the focal contacts at the rear end was needed for the locomotion (23, 53) . A requirement of calpains for certain migratory responses has been demonstrated with the use of calpain inhibitors (54, 55) . In the present study, we used two inhibitors (of both m-and -calpain), calpastatin and ALLM. Both inhibited PGE 2 -mediated migration in EVT cells, substantiating the role of calpain in migration response. Although both m-and -calpain play a role in cell locomotion, they may be differentially activated upon different conditions. For example, m-calpain and not -calpain was shown to be activated upon stimulation of EGF receptor in a murine fibroblast cell line (56); a down-regulation of -calpain with antisense oligonucleotides did not significantly influence EGF-induced cellular calpain activity as well as motility in these cells (56) . Initially, calpain activity was presumed to be solely dependent on [Ca 2ϩ ] i , micromolar levels being required for -calpain and millimolar levels for m-calpain activation (57) . However, recent studies have identified additional mechanisms involved in the regulation of calpain activation such as binding to phospholipids, autoproteolytic cleavage, inhibition by endogenous calpastatin, and activation by phosphorylation (45, 56, 58) .
In the present study, we obtained modest but significant up-regulation of calpain activity by PGE 2 . These effects could be mimicked only by the EP1 agonist 17-phenyl trinor PGE 2 and not by EP4 agonist PGE 1 alcohol. Modest stimulatory effects of PGE 2 and EP1 agonist on calpain activity in whole cell homogenate are likely to be due to its localized stimulation on the cell membrane at the rear end of the cell as opposed to its activation throughout the cell. However, involvement of other Ca 2ϩ -dependent proteases like matrix metalloproteases in PGE 2 -mediated cellular migration cannot be ruled out. These findings of EP1-mediated calpain activation are consistent with a previous report of G q -mediated activation of calpain-induced proteolysis (59) . The observed increase of calpain activity in the absence of exogenous Ca 2ϩ cofactor (Fig. 7B ) is most likely due to the rise of intracellular Ca 2ϩ upon stimulation of cells by the agonists. Its increase in the presence of enzyme saturating concentrations of exogenous Ca 2ϩ (Fig. 7B) indicate novel mechanism(s) of activation of calpain that may not be directly dependent on the rise of [Ca 2ϩ ] i . Calpain phosphorylation could be one such mechanism of its activation because of the presence of several putative phosphorylation sites in this protein (56) . A direct phosphorylation of m-calpain by ERK activation remains a possibility in the cascade of PGE 2 -mediated events, as had been shown with EGF (56) . Calpain has been suggested to cleave focal adhesion proteins like talin, ezrin, and pp125 FAK (30, 53, 58) . Whereas involvement of pp125 FAK was previously demonstrated to play an important role in ligand-induced EVT cell migration (30) it is not known at the moment whether PGE 2 -induced calpain activation can cleave pp125
FAK in EVT cells. These data taken together suggest that PGE 2 -induced activation of calpain involves an increase of intracellular concentration of Ca 2ϩ via EP1 receptors. However, calpain activation by PGE 2 even in the presence of saturating concentrations of exogenous Ca 2ϩ further suggests additional events such as calpain phosphorylation, in the activation process.
A balanced migration/invasiveness of EVT cells into the uterine decidua and uteroplacental arteries appears to be achieved in situ by a large number of regulating factors produced at the fetomaternal interface. Of these, the EGF family acting as autocrine as well as paracrine mediators promotes proliferation of cytotrophoblast (60) and its differentiation into the EVT cell pathway, as evidenced by acquisition of a migratory/invasive phenotype (61) (62) (63) . Other factors which promote EVT cell migration/invasiveness without an influence on proliferation are IGF II, IGFBP-1, uPA, ET-1 and hepatocyte growth factor (HGF), all of which require activation of ERK (an activator of MAPK) for migration stimulation (29 -31, 37, 64) . IGF II is an autocrine mediator acting via IGF type II receptors and by inhibiting adenylyl cyclase and stimulation of MAPK (29) . IGFBP-1 is a paracrine (decidua-derived) mediator acting via ␣5/␤1 integrin receptor, and activation of focal adhesion kinase (FAK) (30) . uPA is an autocrine/paracrine mediator promoting invasiveness by its catalytic function, and migration by binding to the noncatalytic domain of urokinase-type plasminogen activator receptor, activation of PLC, phosphatidylinositol 3-kinase (PI3-K), and rise in [Ca 2ϩ ] i (31) . ET-1 is an autocrine/paracrine mediator acting by activation of ET A/B receptors, increase in [Ca 2ϩ ] i (37) . HGF is a paracrine (mesenchyme-derived) mediator that promotes EVT cell motility and invasiveness (64, 65) by activating c-met receptors, and at least in part by induction of NO (64) . The present study adds PGE 2 (primarily as a paracrine mediator) to this list of migration-promoting factors. The role of [Ca 2ϩ ] i increase appears to be common for numerous migration-promoting ligands, e.g. heparin-binding EGF-like growth factor (62), uPA (31), ET-1 (31), and PGE 2 (present study). In summary, there is substantial commonality and possibly cross-talk among the signaling molecules activated by these migrationpromoting factors. A number of inhibiting factors were shown to control EVT cell migration/invasiveness in situ: decidua-derived TGF␤ (66, 67) , decorin (33) , and TNF␣ (68) . Thus, it is evident that the migration-promoting molecules are produced both by the EVT cells and the decidua, whereas migration-inhibitory factors have primarily a decidual origin. A detailed understanding of the signaling by the migration-promoting and inhibitory ligands as well as their possible derangements in trophoblast hypomigratory/hypoinvasive disorders should be of significant value in identifying molecular targets for prevention and intervention of these diseases.
